[Publication Report] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” Report (March 29, 2024)
date : 4/1/2024
Tags: Dementia
Health and Global Policy Institute (HGPI) has published the report of the online public symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” held on Tuesday, December 12, 2023.
As dementia risk becomes more connected to the individual, this symposium was held to provide an opportunity to consider how civil society should respond to the individualization of risk and what actions should be taken as a whole in order to build an inclusive society.
The symposium introduced ethical issues, the latest studies, and initiatives for dementia risk, including examples from overseas. We shared methods of approaching risks with society from the perspectives of industry, Government, academia, and civil society. In “dementia risk reduction, “we discussed who is it referring to when it says “those who want to (prevent dementia)” as specified in Article 21 of the Dementia Basic Act for Inclusive Society, and the significance of what is included in the Dementia Basic Act. We also deepen discussion on the need for and promotion of industry-academia/public-private collaboration, including how to utilize private sector technologies, products, and services in future dementia prevention efforts.
Based on the report of this symposium, we hope that the discussion on “dementia risk reduction” will be further deepened by domestic and international stakeholders.

[Event Overview]
- Date & Time: Tuesday, December 12, 2023; 17:00 – 20:30 JST
- Format: Online (Zoom Webinars)
- Language: Japanese and English, with simultaneous interpretation
- Participation fee: Free
- Host: Health and Global Policy Institute
- Sponsor:
Integra LifeSciences Corporation.
Splink,Inc.
Sompo Holdings, Inc.
National Graduate Institute for Policy Studies (GRIPS) Global Health Innovation Policy Program (GHIPP)
[Programme] (Titles omitted; in Japanese syllabary order)
| 17:00-17:05 | Opening remarks |
| Hayato Suzuki (Member, House of Representatives / Executive Director, Parliamentary Association for Promoting Dementia Policies for an Inclusive Society) |
|
| 17:05-17:10 | Explanatory introduction |
| Shunichiro Kurita (Senior Manager, HGPI) | |
| Part1 | |
| 17:10-17:35 | Keynote lecture: Ethical Issues on the Individualization of Dementia Risk |
| Shingo Segawa (Project coordinator and Researcher, Department of Medical Ethics and History of Medicine, University Medical Center Göttingen) | |
| 17:35-18:05 | Presentations: The Frontlines of Dementia Risk |
|
Building Evidence through Multifactorial Interventions Developing Communities to Foster Longevity |
|
| Part 2 | |
| 18:10-19:20 | Presentations: Preparing for Dementia Risk as a Society |
|
From the perspective of industry: Necessary Steps to Develop Brain Health From the perspective of industry: Building and Providing a Comprehensive Support Package From the perspective of academia: Preventing Severe Complications Using Robots and Industry-Academia Collaboration From the perspective of academia: Transitioning from Individual Disease Prevention to Community-Building From the perspective of academia: A Form of Dementia that Improves with Treatment and Building Early Detection System From the perspective of civil society: Civil Society-Led Action to Prepare as a Society From the perspective of government: Improving Dementia in the *Me-Byo Stage |
|
| 19:30-20:30 | Discussion: How to Bear the Costs of Prevention and Health Promotion as a Society |
|
Panelists: Moderator: |
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)



